TY - JOUR
AU - Braude, Philip
AU - Carter, Ben
AU - Short, Roxanna
AU - Vilches-Moraga, Arturo
AU - Verduri, Alessia
AU - Quinn, Terence J.
AU - Stechman, Michael
AU - Collins, Jemima T.
AU - Bruce, Eilidh
AU - Einarsson, Alice
AU - Rickard, Frances
AU - Mitchell, Emma
AU - Holloway, Mark
AU - Hesford, James
AU - Barlow-Pay, Fenella
AU - Clini, Enrico
AU - Myint, Phyo Kyaw
AU - Moug, Susan J.
AU - McCarthy, Kathryn
AU - Hewitt, Jonathan
AU - Pearce, Lyndsay
AU - Price, Angeline
PY - 2020
DA - November
TI - The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
JO - International Journal of Cardiovascular Heart & Vasculature
VL - 31
DO - https://doi.org/10.1016/j.ijcha.2020.100660
AB - Objective:During the COVID-19 pandemic the continuation or cessation of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) has been contentious. Mechanisms have been proposed for both beneficial and detrimental effects. Recent studies have focused on mortality with no literature having examined length of hospital stay. The aim of this study was to determine the influence of ACEi and ARBs on COVID-19 mortality and length of hospital stay.
PB - Elsevier
UR - https://aura.abdn.ac.uk/handle/2164/15310
KW - Coronavirus (COVID-19)
KW - Hospital care
ER